Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / cs
-
Total 13F shares
-
25,016
-
Share change
-
+5,602
-
Total reported value
-
$145,622
-
Price per share
-
$5.83
-
Number of holders
-
10
-
Value change
-
+$20,768
-
Number of buys
-
3
-
Number of sells
-
3
Institutional Holders of HELIUS MEDICAL TECHNOLOGIES, INC. - cs (HSDT) as of Q1 2024
As of 31 Mar 2024,
HELIUS MEDICAL TECHNOLOGIES, INC. - cs (HSDT) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,016 shares.
The largest 10 holders included
VANGUARD GROUP INC, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), CoreCap Advisors, LLC, OSAIC HOLDINGS, INC., Federation des caisses Desjardins du Quebec, TORONTO DOMINION BANK, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and ST GERMAIN D J CO INC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.